SCHEMBL6517565

SCHEMBL6517565

O=C(Nc1cc(F)c(N2CCSCC2)c(F)c1F)OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
F10 P00742 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
POLB P06746 1/20 0.42
MGLL Q99685 3/20 0.41
MAOB P27338 1/20 0.41
MGAT2 Q10469 1/20 0.41
DPP4 P27487 2/20 0.41
DPP7 Q9UHL4 2/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6509011 0.87 F10 (0.52) NPC1RAB9AF10POLBMGLL
SCHEMBL6512014 0.86 F13A1 (0.47) NPC1RAB9AF10HDAC1HDAC2
SCHEMBL4011941 0.86 MGLL (0.48) NPC1RAB9APOLBMGLLMAOB
SCHEMBL23525572 0.82 F10 (0.46) NPC1RAB9AF10HDAC3HDAC1
SCHEMBL18396806 0.80 MGLL (0.47) NPC1RAB9APOLBMGLLMAOB
SCHEMBL5945165 0.78 MGAT2 (0.43) NPC1RAB9AF10HDAC3HDAC1
SCHEMBL7037968 0.78 MGLL (0.41) NPC1RAB9APOLBMGLLMAOB
SCHEMBL8306382 0.77 MAPT (0.50) NPC1RAB9APOLBMGLLMAOB
SCHEMBL18787363 0.75 MGLL (0.47) NPC1RAB9APOLBMGLLALDH1A1
SCHEMBL18396765 0.74 MAPT (0.47) NPC1RAB9AMGLLMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005113520-A1 SUBSTITUTED 2,3,5-TRIFLUORPHENYL OXAZOLIDINONES FOR USE AS ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2005-12-01 WO disclosed